Gladstone Institutional Advisory LLC Has $322,000 Stake in Centene Co. (NYSE:CNC)

Gladstone Institutional Advisory LLC grew its position in Centene Co. (NYSE:CNC) by 11.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,281 shares of the company’s stock after purchasing an additional 439 shares during the quarter. Gladstone Institutional Advisory LLC’s holdings in Centene were worth $322,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. First Trust Direct Indexing L.P. grew its position in Centene by 15.3% during the first quarter. First Trust Direct Indexing L.P. now owns 5,046 shares of the company’s stock worth $396,000 after buying an additional 671 shares in the last quarter. Norden Group LLC lifted its stake in Centene by 79.4% during the first quarter. Norden Group LLC now owns 5,878 shares of the company’s stock worth $461,000 after purchasing an additional 2,601 shares during the last quarter. Janney Montgomery Scott LLC lifted its stake in Centene by 5.9% during the first quarter. Janney Montgomery Scott LLC now owns 31,309 shares of the company’s stock worth $2,457,000 after purchasing an additional 1,738 shares during the last quarter. Mutual of America Capital Management LLC lifted its stake in Centene by 0.4% during the first quarter. Mutual of America Capital Management LLC now owns 99,575 shares of the company’s stock worth $7,815,000 after purchasing an additional 445 shares during the last quarter. Finally, Central Pacific Bank Trust Division bought a new stake in Centene during the first quarter worth $93,000. Institutional investors and hedge funds own 93.63% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on CNC shares. StockNews.com cut Centene from a “strong-buy” rating to a “buy” rating in a research note on Monday, October 28th. Truist Financial dropped their price target on Centene from $92.00 to $89.00 and set a “buy” rating for the company in a research note on Monday, July 15th. Jefferies Financial Group cut Centene from a “buy” rating to a “hold” rating and dropped their price target for the company from $83.00 to $69.00 in a research note on Wednesday, July 24th. Oppenheimer decreased their price objective on Centene from $110.00 to $95.00 and set an “outperform” rating for the company in a report on Monday, July 29th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $90.00 price objective on shares of Centene in a report on Tuesday, October 1st. Seven equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $83.92.

Centene Price Performance

CNC stock opened at $63.82 on Tuesday. The company has a market capitalization of $32.22 billion, a P/E ratio of 11.08, a price-to-earnings-growth ratio of 0.85 and a beta of 0.49. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.17 and a current ratio of 1.10. Centene Co. has a 52-week low of $59.77 and a 52-week high of $81.42. The business has a 50-day simple moving average of $70.97 and a two-hundred day simple moving average of $71.89.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.